Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.050 (-2.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed

CNTB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 2021 - 2019
Market Capitalization
136158----
Upgrade
Enterprise Value
92104----
Upgrade
Last Close Price
2.402.82----
Upgrade
PS Ratio
2119.552463.25----
Upgrade
PB Ratio
3.233.76----
Upgrade
P/TBV Ratio
3.233.76----
Upgrade
EV/Sales Ratio
1437.491619.50----
Upgrade
Debt / Equity Ratio
0.020.020.000.010.000
Upgrade
Net Debt / Equity Ratio
-1.04-1.04-1.01-1.16-0.96-0.98
Upgrade
Net Debt / EBITDA Ratio
0.760.765.031.721.322.75
Upgrade
Net Debt / FCF Ratio
0.850.853.842.461.443.04
Upgrade
Asset Turnover
0.000.000.23---
Upgrade
Quick Ratio
3.273.2711.204.699.7615.30
Upgrade
Current Ratio
3.743.7411.464.859.9715.30
Upgrade
Return on Equity (ROE)
-82.72%-82.72%-16.14%-47.96%-54.96%-364.72%
Upgrade
Return on Assets (ROA)
-46.13%-46.13%-10.52%-28.64%-31.27%-26.43%
Upgrade
Return on Capital Employed (ROCE)
-136.80%-136.80%-20.70%-67.60%-73.50%-35.80%
Upgrade
Earnings Yield
-40.90%-35.19%----
Upgrade
FCF Yield
-38.07%-32.76%----
Upgrade
Buyback Yield / Dilution
-0.81%-0.81%-0.27%-0.04%-5.50%-205.31%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.